Martje L. Maas

YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer

Bram Akerboom, Emily S.L. Martens, Milou A.M. Stals, Rolf E. Brouwer et autres

Importance: Although the YEARS algorithm is a safe and efficient way to rule out acute pulmonary embolism (PE), robust evidence on its accuracy in patients with cancer is lacking, and current guidelines suggest proceeding directly to computed tomographic pulmonary angiography (CTPA). Objective: …

nl, us, it, fr, ch, es, be, de (code pays fourni par la source)

Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up

Claudia Recanatini, Corine H. GeurtsvanKessel, Suzan D. Pas, Els M. Broens et autres

BACKGROUND: We aimed to estimate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and describe its determinants and associated symptoms among unvaccinated healthcare workers (HCWs) after the first wave of the pandemic. METHODS: HCWs from 13 Dutch hospitals were screened for …

nl (code pays fourni par la source)

Prior use of anticoagulation is associated with a better survival in COVID-19

A. G. Buenen, Marijn Sinkeldam, Martje L. Maas, Martha Verdonschot et autres

nl (code pays fourni par la source)

Prior use of therapeutic anticoagulation does not protect against COVID‐19 related clinical outcomes in hospitalized patients: A propensity score‐matched cohort study

Janneke Spiegelenberg, Marleen M. H. J. van Gelder, Martje L. Maas, Marcel M.C. Hovens et autres

The hypercoagulable state observed in COVID-19 could be responsible for morbidity and mortality. In this retrospective study we investigated whether therapeutic anticoagulation prior to infection has a beneficial effect in hospitalized COVID-19 patients. This study included 1154 COVID-19 patients admitted to 6 …

nl (code pays fourni par la source)

Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: a propensity score-matched cohort study

Janneke Spiegelenberg, Marleen M. H. J. van Gelder, Martje L. Maas, M. Hovens et autres

The hypercoagulable state observed in COVID-19 could be responsible for morbidity and mortality. In this retrospective study we investigated whether therapeutic anticoagulation prior to infection has a beneficial effect in hospitalized COVID-19 patients. 1154 COVID-19 patients admitted to 6 hospitals in the …

nl (code pays fourni par la source)

Proactieve klinische diabeteszorg met het D-team

Martje L. Maas, M. Heuts, S.P.W.H. van den Heuvel-Bens, S.M. Hendriks et autres

nl (code pays fourni par la source)

[Hypertension due to fibromuscular dysplasia: look for additional disease sites].

Martje L. Maas, Jeanne Margot Kroese, S.J.H. Bredie, C T Postma et autres

Fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic vasculopathy that can lead to arterial stenosis, occlusion, aneurysms, and dissection. FMD of the renal arteries can lead to renovascular hypertension. Percutaneous angioplasty of the renal arteries (PTRA) can lead to normalization of blood pressure …

nl (code pays fourni par la source)

An uncommon cause of Staphylococcus aureus sepsis

Martje L. Maas, Peter C. Wever, Arjan W. Plat, Ellen K. Hoogeveen

We describe a case of Staphylococcus aureus sepsis after acupuncture for chronic fatigue syndrome (CFS). Sepsis is a rare, but potentially fatal complication of acupuncture. The most common cause of bacterial infection after acupuncture is S. aureus. The effectiveness of acupuncture for …

nl, de (code pays fourni par la source)

Exercise-induced Changes in Venous Vascular Function in Nonpregnant Formerly Preeclamptic Women

Ineke Krabbendam, Martje L. Maas, Dick H. J. Thijssen, Wim J.G. Oyen et autres

nl, gb (code pays fourni par la source)